What Affects Willingness to Self-manage a Pessary?

Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT05750615
Collaborator
(none)
132
1
18.2
7.3

Study Details

Study Description

Brief Summary

Pessary self-management is defined as the patient's ability to remove and reinsert their pessary themselves at home. Previous research has suggested that some women may prefer being able to remove and reinsert their pessary as they wish rather than wait for clinic appointments. At the moment, not enough is known about pessary self-management, particularly what makes someone more or less likely to try pessary self-management. The investigators would like to understand this better to try to help women overcome barriers they might face. This study aims to collect data via both questionnaires and interviews to explore willingness to self-manage a pessary. Using findings from the questionnaires and interviews, a group of women who use pessaries and healthcare professionals who provide pessary care will work together to develop a better way to support women to feel able and willing to manage their pessary in future.

Condition or Disease Intervention/Treatment Phase
  • Other: Uncertain what intervention will be co-created

Study Design

Study Type:
Observational
Anticipated Enrollment :
132 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Understanding Factors Which Affect Willingness to Self-manage a Pessary for Pelvic Organ Prolapse: A Mixed Methods Study Aiming to Improve Access to Pessary Self-management.
Actual Study Start Date :
Aug 25, 2022
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Quantitative phase

Pessary using women

Qualitative phase

Pessary using women

Intervention development phase

Pessary using women and pessary practitioners

Pilot phase

Pessary using women

Other: Uncertain what intervention will be co-created
Uncertain what intervention will be co-created

Outcome Measures

Primary Outcome Measures

  1. Willingness to self-manage a pessary [Through study completion, an average of 1 appointment (1 day)]

    Women will be asked whether they are willing or not to self-manage a pessary for prolapse. This will be a binary yes, no or not sure answer.

Secondary Outcome Measures

  1. Age [Through study completion, an average of 1 appointment (1 day)]

    Full years since birth

  2. Pessary [Through study completion, an average of 1 appointment (1 day)]

    Type and size of pessary in situ

  3. Length of pessary management [Through study completion, an average of 1 appointment (1 day)]

    Total months pessary used for

  4. Comorbidities [Through study completion, an average of 1 appointment (1 day)]

    Free text data for participant to report diagnosed health conditionns

  5. Self-management experience [Through study completion, an average of 1 appointment (1 day)]

    The woman will be asked whether she has previously removed or inserted her pessary

  6. Self-management status [Through study completion, an average of 1 appointment (1 day)]

    The woman will be asked whether she is currently self-managing her pessary (defined as removing and inserting it independently in between clinic appointments)

  7. Ethnicity [Through study completion, an average of 1 appointment (1 day)]

    Ethnic groups in accordance with UK government agreed list of ethnicities

  8. Post code [Through study completion, an average of 1 appointment (1 day)]

    Post code at home address to determine deprivation of home address in accordance with UK government index of deprivation

  9. Education status [Through study completion, an average of 1 appointment (1 day)]

    Women will be asked to report their highest level of education

  10. Female genital self-image score (FGSIS) [Through study completion, an average of 1 appointment (1 day)]

    Women will also be asked to complete the Female Genital Self-Image Scale (FGSIS-4), a reliable and validated 4-item questionnaire which measures women's attitude and beliefs about their genitals (Herbenick and Reece, 2010). Scores in the FGSIS-4 range between 4-16, with a mean score of 12 in a nationally representative population of over 2000 American women (Herbenick et al., 2011). Herbenick et al. (2011) have not determined a binary score for high and low FGSIS, however for the purpose of this study, a score of eight or less will indicate low FGSI, whereas more than eight will indicate high FGSI. To score eight or less, a participant must disagree with all four statements describing genital self-image therefore this is deemed to accurately represent FGSIS-4.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

Quantitative phase inclusion criteria

  • Willing and able to give implied consent by completion of the questionnaire

  • Female

  • Over the age of 18 years

  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks

  • Able to speak and understand English

  • Use a ring, shaatz, cube or inflatable pessary

Qualitative phase inclusion criteria

  • Willing and able to give informed consent

  • Female

  • Over the age of 18 years

  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks

  • Speak English or, for those whose first or preferred language is a language other than English, speak a language there is an available interpreter for

Intervention development phase inclusion criteria Pessary using women

  • Willing and able to give informed consent

  • Female

  • Over the age of 18 years

  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks

  • Speak English Pessary practitioners

  • Willing and able to give informed consent

  • Provide regular pessary care as part of clinical role (defined as insertion or removal of a woman's pessary on a minimum of a monthly basis)

  • Speak English

Pilot phase inclusion criteria

  • Willing and able to give informed consent, review the intervention and provide written and/or verbal feedback.

  • Female

  • Over the age of 18 years

  • Have retained a pessary for pelvic organ prolapse for a minimum of two weeks

  • Speak English

  • Have no previous experience self-managing a pessary (defined as never having removed or inserted their pessary, or received any pessary self-management teaching or support from a healthcare professional)

Exclusion Criteria:

Quantitative phase exclusion criteria

  • Lacking capacity to give implied consent by completion of the questionnaire

  • Has a first or preferred language that is not English

  • Use a shelf, gell-horn or donut pessary

Qualitative phase exclusion criteria

  • Lacking capacity to give informed consent

  • First or preferred language that is not English or a language there is an available interpreter for

Intervention development phase exclusion criteria Pessary using women

  • Lacking capacity to give informed consent

  • Does not speak English Pessary practitioners

  • Lacking capacity to give informed consent

  • Does not speak English

  • Does not provide pessary care at a minimum of a monthly basis

Intervention pilot exclusion criteria

  • Lacking capacity to give informed consent, review the intervention and provide written and/or verbal feedback.

  • Does not speak English

  • Have prior experience self-managing a pessary (defined as previously removing or inserting their pessary, or receiving any pessary self-management teaching or support from a healthcare professional)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Manchester University NHS Foundation Trust Manchester United Kingdom M13 9WU

Sponsors and Collaborators

  • Manchester University NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05750615
Other Study ID Numbers:
  • B01328
First Posted:
Mar 1, 2023
Last Update Posted:
Mar 1, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 1, 2023